Record 2025 for TAT Technologies (NASDAQ: TATT) with $178M revenue
TAT Technologies Ltd. reported strong fourth-quarter and full-year 2025 results, marking a third consecutive year of growth and improved profitability. Full-year revenue reached a record $178 million, with margin expansion across all profitability measures and a record high EBITDA margin.
Net income for 2025 was $16.8 million, and Adjusted EBITDA was $25.5 million, both higher than 2024. Fourth-quarter revenue showed organic growth of over 13%. The company ended 2025 with backlog and long-term agreements of about $550 million, up from $429 million, and cash and cash equivalents of $51.3 million, while shareholders’ equity increased to $176.4 million.
Positive
- Record 2025 performance with revenue of $178 million, net income of $16.8 million, and Adjusted EBITDA of $25.5 million, alongside backlog and long-term agreements of about $550 million, indicating strong demand and improved profitability.
Negative
- None.
Insights
Record 2025 growth, stronger margins and backlog support a positive fundamental trend.
TAT Technologies delivered record 2025 revenue of $178 million, with net income rising to $16.8 million and Adjusted EBITDA to $25.5 million. Management highlights margin expansion across all profitability metrics and organic growth of over 13% in the fourth quarter.
The backlog and long-term agreements rose to approximately $550 million from $429 million, giving multi-year revenue visibility. The balance sheet also strengthened: cash and cash equivalents increased to $51.3 million and total shareholders’ equity to $176.4 million, helped by public share offerings and retained earnings.
Overall, the combination of higher revenue, improved profitability, larger backlog and stronger liquidity suggests operational momentum heading into 2026, particularly in the company’s core aviation MRO and heat transfer businesses. Future disclosures may show how effectively this backlog converts into revenue and cash flow.
|
Item/Exhibit No.
|
Description
|
|
|
99.1
|
Press Release dated March 18, 2026 re: TAT Technologies Ltd. Reports 2025 Results.
|
| TAT TECHNOLOGIES LTD. | |||
| (Registrant) | |||
|
By:
|
/s/ Ehud Ben-Yair | ||
| Ehud Ben-Yair | |||
| Chief Financial Officer | |||
| • |
Revenues: increased by 13.4% to $46.5 million compared to $41.0 million for the fourth quarter of 2024. For the twelve months of 2025, revenues increased by 17.0% to $178.0 million compared to
$152.1 million for the same period in 2024.
|
| • |
Gross Profit: increased by 23.6% to $11.7 million (25.2% of revenues) compared to $9.5 million (23.1% of revenues) for the fourth quarter of 2024. For the twelve months of 2025, gross profit
increased by 33.6% to $44.1 million (24.8% of revenues) compared to $33.0 million (21.7% of revenues) for the same period in 2024.
|
| • |
Operating Income: increased by 20.2% to $4.9 million (10.6% of revenues) compared to $4.1 million (10.0% of revenues) for the fourth quarter of 2024. For the twelve months of 2025, operating income
increased by 50.5% to $18.8 million (10.6% of revenues) compared to $12.5 million (8.2% of revenues) for the same period in 2024.
|
| • |
Net Income: increased by 32.2% to $4.7 million compared to $3.6 million for the fourth quarter of 2024. For the twelve months of 2025, net income increased by 50.6% to $16.8 million compared to
$11.2 million for the same period in 2024.
|
| • |
Adjusted EBITDA: increased by 24.0% to $6.9 million (14.8% of revenues) compared to $5.5 million (13.5% of revenues) for the fourth quarter of 2024. Adjusted EBITDA for the twelve months of 2025
increased by 36.7% to $25.5 million (14.3% of revenues) compared to $18.6 million (12.2% of revenues) for the same period in 2024.
|
| • |
Cash flow provided from operating activities for the three and twelve months ended December 31, 2025, was $5.6 million and $15.0 million, respectively, compared to cash flows used in operating
activities of ($1.0) million and $(5.8) million for the three and twelve months ended December 31, 2024, respectively.
|
|
December 31,
|
||||||||
|
2025
|
2024
|
|||||||
|
ASSETS
|
||||||||
|
CURRENT ASSETS:
|
||||||||
|
Cash and cash equivalents
|
$
|
51,259
|
$
|
7,129
|
||||
|
Accounts receivable, net of allowance for credit losses of $172
and $400 thousands as of December 31, 2025 and 2024, respectively |
33,420
|
29,697
|
||||||
|
Inventory
|
75,549
|
68,540
|
||||||
|
Prepaid expenses and other current assets
|
6,071
|
7,848
|
||||||
|
Total current assets
|
166,299
|
113,214
|
||||||
|
NON-CURRENT ASSETS:
|
||||||||
|
Property, plant and equipment, net
|
46,922
|
41,576
|
||||||
|
Operating lease right of use assets
|
5,807
|
2,282
|
||||||
|
Intangible assets, net
|
1,452
|
1,553
|
||||||
|
Investment in affiliates
|
4,905
|
2,901
|
||||||
|
Restricted deposit
|
307
|
305
|
||||||
|
Funds in respect of employee rights upon retirement
|
398
|
654
|
||||||
|
Deferred tax assets
|
639
|
877
|
||||||
|
Total non-current assets
|
60,430
|
50,148
|
||||||
|
Total assets
|
$
|
226,729
|
$
|
163,362
|
||||
|
December 31,
|
||||||||
|
2025
|
2024
|
|||||||
|
LIABILITIES AND SHAREHOLDERS 'EQUITY
|
||||||||
|
CURRENT LIABILITIES:
|
||||||||
|
Current maturities of long-term loans
|
$
|
2,227
|
$
|
2,083
|
||||
|
Short term loans
|
-
|
4,350
|
||||||
|
Accounts payable
|
12,986
|
12,158
|
||||||
|
Accrued expenses and other
|
17,296
|
18,594
|
||||||
|
Current maturities of operating lease liabilities
|
1,474
|
939
|
||||||
|
Total current liabilities
|
33,983
|
38,124
|
||||||
|
NON-CURRENT LIABILITIES:
|
||||||||
|
Long-term loans
|
9,485
|
10,938
|
||||||
|
Operating lease liabilities
|
4,448
|
1,345
|
||||||
|
Liability in respect of employee rights upon retirement
|
770
|
986
|
||||||
|
Deferred tax liabilities
|
1,652
|
-
|
||||||
|
Total non-current liabilities
|
16,355
|
13,269
|
||||||
|
COMMITMENTS AND CONTINGENCIES (NOTE 11)
|
||||||||
|
Total liabilities
|
50,338
|
51,393
|
||||||
|
SHAREHOLDERS 'EQUITY:
|
||||||||
|
Ordinary shares of NIS 0 par value. Authorized: 19,000,000 shares at December 31, 2025 and 13,000,000 shares at December 31, 2024
Issued:13,257,610 and 11,214,831 shares at December 31, 2025 and 2024, respectively
Outstanding: 12,983,137 and 10,940,358 shares at December 31, 2025 and 2024, respectively
|
-
|
-
|
||||||
|
Additional paid-in capital
|
136,578
|
89,697
|
||||||
|
Treasury shares, at cost, 274,473 shares at December 31, 2025 and 2024
|
(2,088
|
)
|
(2,088
|
)
|
||||
|
Accumulated other comprehensive income (loss)
|
643
|
(76
|
)
|
|||||
|
Retained earnings
|
41,258
|
24,436
|
||||||
|
Total shareholders' equity
|
176,391
|
111,969
|
||||||
|
Total liabilities and shareholders' equity
|
$
|
226,729
|
$
|
163,362
|
||||
|
Three Months Ended
December 31
|
Year ended
December 31,
|
|||||||||||||||
|
2025
|
2024
|
2025
|
2024
|
|||||||||||||
|
Revenues:
|
||||||||||||||||
|
Products
|
$
|
13,046
|
$
|
11,879
|
$
|
50,850
|
$
|
47,710
|
||||||||
|
Services
|
33,488
|
29,165
|
127,165
|
104,406
|
||||||||||||
|
46,534
|
41,044
|
178,015
|
152,116
|
|||||||||||||
|
Cost of revenue:
|
||||||||||||||||
|
Products
|
9,180
|
8,792
|
35,793
|
33,986
|
||||||||||||
|
Services
|
25,636
|
22,769
|
98,124
|
85,116
|
||||||||||||
|
34,816
|
31,561
|
133,917
|
119,102
|
|||||||||||||
|
Gross profit
|
11,718
|
9,483
|
44,098
|
33,014
|
||||||||||||
|
Operating expenses:
|
||||||||||||||||
|
Research and development, net
|
497
|
302
|
1,384
|
1,248
|
||||||||||||
|
Selling and marketing
|
2,470
|
2,099
|
8,576
|
7,746
|
||||||||||||
|
General and administrative
|
4,208
|
2,961
|
15,730
|
11,901
|
||||||||||||
|
Other (income) expense
|
(404
|
)
|
7
|
(404
|
)
|
(383
|
)
|
|||||||||
|
6,771
|
5,369
|
25,286
|
20,512
|
|||||||||||||
|
Operating income
|
4,947
|
4,114
|
18,812
|
12,502
|
||||||||||||
|
Interest expenses
|
175
|
289
|
1,010
|
1,472
|
||||||||||||
|
Other financial expenses, net
|
32
|
169
|
325
|
477
|
||||||||||||
|
Income before taxes on income
|
4,740
|
3,656
|
17,477
|
10,553
|
||||||||||||
|
Provision for taxes on income
|
519
|
289
|
2,143
|
195
|
||||||||||||
|
Income before share of equity investment
|
4,221
|
3,367
|
15,334
|
10,358
|
||||||||||||
|
Share in profits of equity investment of affiliated companies
|
505
|
208
|
1,488
|
809
|
||||||||||||
|
Net income
|
$
|
4,726
|
$
|
3,575
|
$
|
16,822
|
$
|
11,167
|
||||||||
|
Three Months Ended
December 31
|
Year ended
December 31,
|
|||||||||||||||
|
2025
|
2024
|
2025
|
2024
|
|||||||||||||
|
Net income
|
$
|
4,726
|
$
|
3,575
|
$
|
16,822
|
$
|
11,167
|
||||||||
|
Earnings per share
|
||||||||||||||||
|
Basic
|
$
|
0.36
|
$
|
0.33
|
$
|
1.39
|
$
|
1.08
|
||||||||
|
Diluted
|
$
|
0.36
|
$
|
0.32
|
$
|
1.37
|
$
|
1.00
|
||||||||
|
Weighted average number of shares outstanding
|
||||||||||||||||
|
Basic
|
12,959,476
|
10,887,540
|
12,075,678
|
10,363,978
|
||||||||||||
|
Diluted
|
13,093,285
|
11,707,622
|
12,283,312
|
11,215,827
|
||||||||||||
|
Three Months Ended
December 31,
|
Year ended
December 31,
|
|||||||||||||||
|
2025
|
2024
|
2025
|
2024
|
|||||||||||||
|
Net income
|
$
|
4,726
|
$
|
3,575
|
$
|
16,822
|
$
|
11,167
|
||||||||
|
Other comprehensive income (loss), net:
|
||||||||||||||||
|
Net unrealized losses from derivatives
|
-
|
-
|
-
|
(27
|
)
|
|||||||||||
|
Change in foreign currency translation adjustments
|
144
|
(197
|
)
|
719
|
(76
|
)
|
||||||||||
|
Total comprehensive income
|
$
|
4,870
|
$
|
3,378
|
$
|
17,541
|
$
|
11,064
|
||||||||
|
Ordinary shares
|
Accumulated
|
|||||||||||||||||||||||||||
|
Number of shares issued
|
Amount
|
Additional paid-in capital
|
other comprehensive income (loss)
|
Treasury shares
|
Retained earnings
|
Total shareholders’ equity
|
||||||||||||||||||||||
|
BALANCE AT DECEMBER 31, 2022
|
9,186,019
|
$
|
2,842
|
$
|
66,245
|
$
|
(26
|
)
|
$
|
(2,088
|
)
|
$
|
8,597
|
$
|
75,570
|
|||||||||||||
|
CHANGES DURING THE YEAR ENDED DECEMBER 31, 2023:
|
||||||||||||||||||||||||||||
|
Comprehensive income
|
-
|
-
|
-
|
53
|
-
|
4,672
|
4,725
|
|||||||||||||||||||||
|
Exercise of options
|
32,466
|
8
|
157
|
-
|
-
|
-
|
165
|
|||||||||||||||||||||
|
Issuance of common shares net of issuance costs of $141 thousands
|
1,158,600
|
290
|
9,774
|
-
|
-
|
-
|
10,064
|
|||||||||||||||||||||
|
Share based compensation
|
-
|
-
|
159
|
-
|
-
|
-
|
159
|
|||||||||||||||||||||
|
BALANCE AT DECEMBER 31, 2023
|
10,377,085
|
3,140
|
76,335
|
27
|
(2,088
|
)
|
13,269
|
90,683
|
||||||||||||||||||||
|
CHANGES DURING THE YEAR ENDED DECEMBER 31, 2024:
|
||||||||||||||||||||||||||||
|
Comprehensive income (loss)
|
-
|
-
|
-
|
(103
|
)
|
-
|
11,167
|
11,064
|
||||||||||||||||||||
|
Exercise of options
|
164,406
|
12
|
(12
|
)
|
-
|
-
|
-
|
-
|
||||||||||||||||||||
|
Cancel of shares par value
|
-
|
(3,152
|
)
|
3,152
|
-
|
-
|
-
|
-
|
||||||||||||||||||||
|
Issuance of common shares net of issuance costs of $162 thousands
|
673,340
|
-
|
9,827
|
-
|
-
|
-
|
9,827
|
|||||||||||||||||||||
|
Share based compensation
|
-
|
-
|
395
|
-
|
-
|
-
|
395
|
|||||||||||||||||||||
|
BALANCE AT DECEMBER 31, 2024
|
11,214,831
|
-
|
89,697
|
(76
|
)
|
(2,088
|
)
|
24,436
|
111,969
|
|||||||||||||||||||
|
CHANGES DURING THE YEAR ENDED DECEMBER 31, 2025:
|
||||||||||||||||||||||||||||
|
Comprehensive income
|
-
|
-
|
-
|
719
|
-
|
16,822
|
17,541
|
|||||||||||||||||||||
|
Exercise of options
|
175,481
|
-
|
282
|
-
|
-
|
-
|
282
|
|||||||||||||||||||||
|
Issuance of common shares on public offering, net of issuance costs of $2,769 thousands
|
1,625,000
|
-
|
39,415
|
-
|
-
|
-
|
39,415
|
|||||||||||||||||||||
|
Exercise of the underwriters' option on public offering, net of issuance costs of $413 thousands
|
242,298
|
-
|
5,953
|
-
|
-
|
-
|
5,953
|
|||||||||||||||||||||
|
Share based compensation
|
-
|
-
|
1,231
|
-
|
-
|
-
|
1,231
|
|||||||||||||||||||||
|
BALANCE AT DECEMBER 31, 2025
|
13,257,610
|
$
|
-
|
$
|
136,578
|
$
|
643
|
$
|
(2,088
|
)
|
$
|
41,258
|
$
|
176,391
|
||||||||||||||
|
Three Months Ended
December 31,
|
Year ended
December 31, |
|||||||||||||||
|
2025
|
2024
|
2025
|
2024
|
|||||||||||||
|
CASH FLOWS FROM OPERATING ACTIVITIES:
|
||||||||||||||||
|
Net income
|
$
|
4,726
|
$
|
3,575
|
$
|
16,822
|
$
|
11,167
|
||||||||
|
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
|
||||||||||||||||
|
Depreciation and amortization
|
1,339
|
1,136
|
5,101
|
5,455
|
||||||||||||
|
Loss (gain) from change in fair value of derivatives
|
-
|
22
|
-
|
22
|
||||||||||||
|
Net change in operating right of use asset and operating lease liability
|
112
|
18
|
112
|
18
|
||||||||||||
|
Noncash financial expenses (income)
|
1,247
|
79
|
1,881
|
(187
|
)
|
|||||||||||
|
Decrease in restructuring plan provision
|
-
|
(63
|
)
|
-
|
(63
|
)
|
||||||||||
|
Change in allowance for credit losses
|
(149
|
)
|
55
|
(228
|
)
|
55
|
||||||||||
|
Share in results of affiliated companies
|
(505
|
)
|
(208
|
)
|
(1,488
|
)
|
(809
|
)
|
||||||||
|
Share based compensation
|
551
|
185
|
1,231
|
395
|
||||||||||||
|
Capital gains from sale of property, plant and equipment
|
(401
|
)
|
(123
|
)
|
(401
|
)
|
(478
|
)
|
||||||||
|
Deferred income taxes, net
|
424
|
208
|
1,890
|
117
|
||||||||||||
|
Changes in operating assets and liabilities:
|
||||||||||||||||
|
Decrease (increase) in trade accounts receivable
|
59
|
(37
|
)
|
(3,495
|
)
|
(9,743
|
)
|
|||||||||
|
Decrease (increase) in other current assets and prepaid expenses
|
394
|
(625
|
)
|
2,235
|
(1,463
|
)
|
||||||||||
|
Decrease (increase) in inventory
|
1,520
|
(6,510
|
)
|
(7,532
|
)
|
(17,165
|
)
|
|||||||||
|
Increase (decrease) in trade accounts payable
|
(4,381
|
)
|
(746
|
)
|
359
|
2,170
|
||||||||||
|
Increase (decrease) in accrued expenses and other
|
629
|
2,073
|
(1,513
|
)
|
4,691
|
|||||||||||
|
Net cash provided by (used in) operating activities
|
5,565
|
(961
|
)
|
14,974
|
(5,818
|
)
|
||||||||||
|
CASH FLOWS FROM INVESTING ACTIVITIES:
|
||||||||||||||||
|
Proceeds from sale of property, plant and equipment
|
900
|
-
|
900
|
1,275
|
||||||||||||
|
Purchase of property, plant and equipment
|
(2,044
|
)
|
(1,569
|
)
|
(10,954
|
)
|
(5,126
|
)
|
||||||||
|
Net cash used in investing activities
|
(1,144
|
)
|
(1,569
|
)
|
(10,054
|
)
|
(3,851
|
)
|
||||||||
|
Three Months Ended
December 31,
|
Year ended
December 31, |
|||||||||||||||
|
2025
|
2024
|
2025
|
2024
|
|||||||||||||
|
CASH FLOWS FROM FINANCING ACTIVITIES:
|
||||||||||||||||
|
Repayments of long-term loans
|
$
|
(528
|
)
|
$
|
(562
|
)
|
$
|
(2,088
|
)
|
$
|
(2,016
|
)
|
||||
|
Net change in short term loans
|
-
|
1,754
|
(4,350
|
)
|
(7,650
|
)
|
||||||||||
|
Proceeds from issuance of ordinary shares and exercise of underwriters’ option
|
-
|
-
|
48,550
|
9,827
|
||||||||||||
|
Issuance costs of ordinary shares and exercise of the underwriters' option
|
-
|
(96
|
)
|
(3,182
|
)
|
-
|
||||||||||
|
Proceeds from exercise of options
|
282
|
-
|
282
|
-
|
||||||||||||
|
Net cash provided by (used in) financing activities
|
(246
|
)
|
1,096
|
39,212
|
161
|
|||||||||||
|
Net increase (decrease) in cash and cash equivalents and restricted cash
|
4,175
|
(1,434
|
)
|
44,132
|
(9,508
|
)
|
||||||||||
|
Cash and cash equivalents and restricted cash at beginning of period
|
47,391
|
8,868
|
7,434
|
16,942
|
||||||||||||
|
Cash and cash equivalents and restricted cash at end of period
|
$
|
51,566
|
$
|
7,434
|
$
|
51,566
|
$
|
7,434
|
||||||||
|
Supplementary information on investing and financing activities not involving cash flows:
|
||||||||||||||||
|
Additions of operating lease right-of-use assets and operating lease liabilities
|
104
|
165
|
3,859
|
983
|
||||||||||||
|
Reclassification of inventory to property, plant and equipment
|
-
|
95
|
579
|
155
|
||||||||||||
|
Supplemental disclosure of cash flow information:
|
||||||||||||||||
|
Interest paid
|
55
|
111
|
1,001
|
1,400
|
||||||||||||
|
Three Months Ended
December 31,
|
Year ended
December 31,
|
|||||||||||||||
|
2025
|
2024
|
2025
|
2024
|
|||||||||||||
|
Net income
|
$
|
4,726
|
$
|
3,575
|
$
|
16,822
|
$
|
11,167
|
||||||||
|
Adjustments:
|
||||||||||||||||
|
Share in results and sale of equity investment of affiliated companies
|
(505
|
)
|
(208
|
)
|
(1,488
|
)
|
(809
|
)
|
||||||||
|
Provision for income taxes
|
519
|
289
|
2,143
|
195
|
||||||||||||
|
Financial expenses, net
|
207
|
458
|
1,335
|
1,949
|
||||||||||||
|
Depreciation and amortization
|
1,385
|
1,254
|
5,410
|
5,717
|
||||||||||||
|
Share based compensation
|
551
|
185
|
1,231
|
395
|
||||||||||||
|
Adjusted EBITDA
|
$
|
6,883
|
$
|
5,553
|
$
|
25,453
|
$
|
18,614
|
||||||||
FAQ
How did TAT Technologies (TATT) perform financially in 2025?
What were TAT Technologies’ fourth-quarter 2025 results?
How large was TAT Technologies’ backlog at the end of 2025?
What happened to TAT Technologies’ profitability metrics in 2025?
How strong is TAT Technologies’ balance sheet after 2025?
What non-GAAP measure does TAT Technologies highlight for 2025?
Filing Exhibits & Attachments
1 documentPress Releases